文献速递免疫规划卫生政策与健康促进

利用人群数据推广成人免疫复合测量

Promoting Adult Immunization Using Population-Based Data for a Composite Measure.
PubMed 文献 · Am J Prev Med · 2018-08-19

该研究利用2015年美国国家健康访谈调查数据,计算19岁及以上成人中多种常规推荐疫苗的复合接种覆盖率,并分析不同年龄组的差异。结果显示,包含流感疫苗的复合覆盖率较低(11.9%),排除流感后为20.7%;多数成人至少需要补种一种疫苗。研究认为调查数据可能高估或低估覆盖率,但复合测量有助于促进成人免疫依从性。

要点

  • 包含流感疫苗的复合覆盖率在19岁及以上成人中为11.9%,60-64岁组最低(6.3%),19-59岁组最高(13.7%)。
  • 排除流感疫苗后,复合覆盖率为20.7%,60-64岁组为8.1%,19-59岁组为25.2%。
  • 使用过去10年内任何含破伤风类毒素疫苗的复合定义时,包含流感疫苗的覆盖率为23.4%,排除流感后为51.4%。

核心结论

  • 基于调查的疫苗接种数据可能高估或低估覆盖率,但按任何指标衡量,大多数成人至少需要额外接种一种疫苗。
  • 复合测量为促进成人免疫接种依从性提供了单一焦点。

研究设计与样本

  • 使用2015年美国国家健康访谈调查数据,于2017年计算19岁及以上成人中选定的常规推荐疫苗的复合覆盖率,并分19-59岁、60-64岁和65岁及以上三个年龄组进行分析。

主要发现

  • 包含过去10年内接种破伤风-白喉类毒素(Td)或破伤风-白喉-无细胞百日咳疫苗(Tdap)及流感疫苗的复合覆盖率在19岁及以上成人中为11.9%,60-64岁组为6.3%,19-59岁组为13.7%。
  • 排除流感疫苗后,上述复合覆盖率为20.7%,60-64岁组为8.1%,19-59岁组为25.2%。
  • 使用过去10年内任何含破伤风类毒素疫苗的复合定义时,包含流感疫苗的覆盖率为23.4%,60-64岁组为12.6%,19-59岁组为25.7%。
  • 排除流感疫苗后,该复合覆盖率为51.4%,60-64岁组为15.8%,19-59岁组为63.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 基于调查的疫苗接种数据可能低估或高估覆盖率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A composite adult immunization status measure is currently under consideration for adoption into the Healthcare Effectiveness Data and Information Set. This paper complements the Healthcare Effectiveness Data and Information Set health plan-level measure testing efforts by examining use of survey-based self-reported vaccination data to assess composite adult immunization coverage and identify limitations to using survey data to measure progress. METHODS: The 2015 National Health Interview Survey data were used in 2017 to calculate estimates for a composite of selected vaccines routinely recommended for adults aged ≥19 years, overall and in three age groups: 19-59, 60-64, and ≥65 years for tetanus and diphtheria toxoids (Td); tetanus toxoid; reduced diphtheria toxoid; and tetanus, diphtheria, acellular pertussis vaccine (Tdap); and herpes zoster, pneumococcal, and influenza vaccines. RESULTS: Composite coverage for adults aged ≥19 years including receipt of Tdap in the past 10 years and influenza vaccination was 11.9%, ranging from 6.3% in adults aged 60-64 years to 13.7% in adults aged 19-59 years. Excluding influenza, composite coverage was 20.7%, ranging from 8.1% (adults aged 60-64 years) to 25.2% (adults aged 19-59 years). In a composite including any Td-containing vaccine in the past 10 years, coverage including influenza vaccination for adults aged ≥19 years was 23.4%, ranging from 12.6% (adults aged 60-64 years) to 25.7% (adults aged 19-59 years). Excluding influenza, composite coverage was 51.4%, ranging from 15.8% (adults aged 60-64 years) to 63.0% (adults aged 19-59 years). CONCLUSIONS: Survey-based vaccination data may under- or over-estimate coverage, but most adults require at least one additional vaccination by any metric. A composite measure provides a single focal point to promote adherence to standards of care.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Shen AK, Williams WW, O'Halloran AC, et al. Promoting Adult Immunization Using Population-Based Data for a Composite Measure. Am J Prev Med. 2018. PMID: 30135039. doi:10.1016/j.amepre.2018.04.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。